Addressing Diabetes Stigma Through Leadership and Policy

Reflections from the World Diabetes Day panel in Malta

In November, within the Parliament of Malta, a dedicated panel discussion brought focused attention to an issue that continues to shape the lives of people living with diabetes across all regions and income settings: stigma.

Convened as part of the PDGN Global Forum and held in the context of World Diabetes Day, the session provided a structured space for political leaders, health experts, and patient advocates to reflect on how stigma influences access to care, participation in public life, and health outcomes.

Framing Stigma as a Policy Consideration

The discussion emphasized that stigma is not solely a social or cultural concern. It has direct implications for public policy. When individuals delay diagnosis, avoid disclosure in professional settings, or disengage from care due to fear of judgment, the consequences are reflected in national health indicators, productivity, and long term system costs. Panelists highlighted the importance of recognising stigma as a barrier that must be addressed through policy design, health system practices, and workplace frameworks.

Leadership and Visibility

A central moment of the panel was the contribution of Rt. Hon. The Baroness May of Maidenhead, whose presence underscored the role of political leadership in shaping public discourse on diabetes. Drawing on her experience as a senior public servant living with type 1 diabetes, she spoke about the value of openness in public life and the responsibility of leaders to contribute to normalising chronic conditions. Her intervention reinforced the message that visibility at the highest levels can help reduce misconceptions and foster more inclusive institutional cultures.

Clinical and Global Perspectives

Representing the International Diabetes Federation during the session, Dr. Jackie Kassouf Maalouf provided clinical insight into how stigma affects patient engagement and self management. She highlighted how attitudes within healthcare settings, time constraints, and limited patient education can unintentionally reinforce feelings of blame or isolation. Her remarks linked individual experiences to broader system level challenges, stressing the need for supportive and person centered models of care.

Community Voices at the Center

The panel also ensured that lived experience remained central to the discussion. Ana Alvarez reflected on the daily realities faced by people living with diabetes, including language used in public narratives, expectations around self management, and the emotional impact of constant scrutiny. Her contribution reinforced the importance of including patient voices in policy discussions, not as an add on, but as a core element of effective decision making.

Guiding a Constructive Dialogue

The session was moderated by Sana Ajmal, who facilitated a balanced and forward looking exchange between panelists. Through targeted questions and careful stewardship of the discussion, the panel maintained a focus on solutions and shared responsibility across sectors.

Key Takeaways from Malta

The World Diabetes Day stigma panel in Malta highlighted several important considerations for policymakers and institutions:

• Stigma has measurable implications for health systems and must be addressed within national diabetes strategies
• Political leadership and visibility play a critical role in shaping public understanding
• Health systems and workplaces must be designed to support openness and inclusion
• Patient perspectives are essential to informed and effective policy responses

The discussion offered a clear message. Addressing diabetes stigma requires sustained leadership, thoughtful policy, and collaboration across political, clinical, and community spheres. The conversation in Malta marked an important step in that direction.